GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹5.22 Cr | ₹0.41 Cr | ₹5.79 Cr | ₹-3.51 Cr | ₹3.12 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GUJARAT THEMIS BIOSYN ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹5.22 Cr |
| Mar2024 | ₹0.41 Cr |
| Mar2023 | ₹5.79 Cr |
| Mar2022 | ₹-3.51 Cr |
| Mar2021 | ₹3.12 Cr |
How is Net Cash Inflow / Outflow of GUJARAT THEMIS BIOSYN Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.22 Cr | 1,162.08 | |
| Mar2024 | ₹0.41 Cr | -92.85 | |
| Mar2023 | ₹5.79 Cr | Positive | |
| Mar2022 | ₹-3.51 Cr | Negative | |
| Mar2021 | ₹3.12 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,151.8 Cr | 8% | 7.2% | 3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 8% |
7.2% |
3.3% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses